Latest Articles

Publication Date
All News Scientific
Calls grow for Jamberoo Preschool lease extension until a new site is ready - The Bugle Newspaper

Calls grow for Jamberoo Preschool lease extension until a new site is ready The Bugle Newspaper

Published: Dec. 12, 2024, 12:27 a.m.
Read Full Article
Health Workers Get Farmer Drunk, Trick Him Into Unwanted Vasectomy Weeks Before Marriage: Report - Medical Daily

Health Workers Get Farmer Drunk, Trick Him Into Unwanted Vasectomy Weeks Before Marriage: Report Medical Daily

Published: Dec. 11, 2024, 8:01 p.m.
Read Full Article
Catamenial Pneumothorax in a Patient Undergoing Low-Dose Estrogen-Progestin Therapy: A Case Report - Cureus

Catamenial Pneumothorax in a Patient Undergoing Low-Dose Estrogen-Progestin Therapy: A Case Report Cureus

Published: Dec. 11, 2024, 1:59 p.m.
Read Full Article
Primary Umbilical Endometriosis (Villar’s Nodule): A Case Report - Dove Medical Press

Primary Umbilical Endometriosis (Villar’s Nodule): A Case Report Dove Medical Press

Published: Dec. 11, 2024, 7:09 a.m.
Read Full Article
An Unusual Case of Pelvic Congestion Syndrome: A Case Report - Cureus

An Unusual Case of Pelvic Congestion Syndrome: A Case Report Cureus

Published: Dec. 11, 2024, 4:33 a.m.
Read Full Article
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - BioSpace

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer BioSpace

Published: Dec. 10, 2024, 12:23 p.m.
Read Full Article
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - Yahoo Finance

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer Yahoo Finance

Published: Dec. 10, 2024, 11 a.m.
Read Full Article
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - PR Newswire

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer PR Newswire

Published: Dec. 10, 2024, 11 a.m.
Read Full Article
IDEAYA Launches Breakthrough Phase 1 Trial: Novel PARG Inhibitor + KEYTRUDA for Endometrial Cancer - StockTitan

IDEAYA Launches Breakthrough Phase 1 Trial: Novel PARG Inhibitor + KEYTRUDA for Endometrial Cancer StockTitan

Published: Dec. 10, 2024, 11 a.m.
Read Full Article
Eating Candy and Cake Linked to Reduced Risk of Heart Disease in Stunning New Study - Medical Daily

Eating Candy and Cake Linked to Reduced Risk of Heart Disease in Stunning New Study Medical Daily

Published: Dec. 9, 2024, 10 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!